1919 Investment Counsel’s Celgene Corp CELG Stock Holding History

1919 Investment Counsel’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$65.6M	Sell	692,618 -31,928	-4%	-$2.88M	1.35%	11
2014 Q2	$62.2M	Sell	724,546 -25,658	-3%	-$1.95M	1.27%	13
2014 Q1	$52.4M	Sell	750,204 -225,904	-23%	-$17.9M	1.07%	28
2013 Q4	$82.5M	Sell	976,108 -18,352	-2%	-$1.45M	1.72%	5
2013 Q3	$76.6M	Sell	994,460 -19,160	-2%	-$1.34M	1.72%	4
2013 Q2	$59.3M	Buy	+1,013,620	New	+$61M	1.39%	10

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

1919 Investment Counsel's CELG Position: Q3 2014 in Review

1919 Investment Counsel reduced its Celgene Corp (CELG) stake by 4.4% in Q3 2014, selling an estimated $2.88M and leaving 692,618 shares worth $65.6M. The position accounts for 1.35% of the portfolio, ranked #11.

1919 Investment Counsel first reported a position in CELG in Q2 2013 and has held it in 6 quarters since. The position peaked at $82.5M in Q4 2013. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

1919 Investment Counsel held 692,618 shares of Celgene Corp worth $65.6M as of Q3 2014.
1919 Investment Counsel sold 31,928 Celgene Corp shares in Q3 2014, an estimated $2.88M.
Celgene Corp made up 1.35% of 1919 Investment Counsel's portfolio in Q3 2014, its #11 holding.
1919 Investment Counsel first reported a position in Celgene Corp in Q2 2013 and has held it in 6 quarters since.
1919 Investment Counsel's Celgene Corp position peaked at $82.5M in Q4 2013.
1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.